Su Shao-Fei, Tian Yu-Feng, Chen Lin-Bao, Yan Bo
Department of Vascular surgery, Yinchuan First People's Hospital, Yinchuan 750021, Ningxia Hui Autonomous Region, China. E-mail:
Department of Vascular surgery, Yinchuan First People's Hospital, Yinchuan 750021, Ningxia Hui Autonomous Region, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Oct;25(5):1509-1513. doi: 10.7534/j.issn.1009-2137.2017.05.040.
To investigate the therapeutic efficacy of anticoagulation(AC) and its combination with catheter-directed thrombolysis(CDT) for deep venous thrombosis of lower extremities.
One hundred and thirty-nine patients with deep venous thrombosis of early lower extremities treated in our hospital from May 2011 to September 2013 were selected and randomly divided into the AC group(n= 66) and CDT+AC group(n= 73). The thrombolytic effects, adverse reactions, post-thrombotic syndrome (PTS) and quality of life were evaluated.
There were no serious adverse events during treatment and after treatment in the 2 groups. Hematomas in 2 cases and gross hematuria in 3 cases were observed in the CDT+AC group. The gums bleed or gross hematuria in 3 cases were observed in the AC group. Compared with the AC group, the number of grade I thrombolysis in CDT+AC group decreased significantly (60.61% vs 9.59%)(P< 0.05), and the number of grade III thrombolysis increased significantly(7.57% vs 49.31%)(P< 0.05). During follow-up, the incidence of PTS in both groups showed increase year by year, and none of the patients had severe PTS. The incidence PTS in CDT+AC group at 12 months and 18 months were lower than those of AC group(17.81% vs 33.33%, 24.66% vs 43.94%)(P< 0.05). Compared with the AC group, the scores of physiological role and vitality in CDT+AC group at 6 months, 12 months and 18 months were higher (P< 0.05).
Catheter-directed thrombolysis combined with AC therapy can promote the mitigation of clinical symptoms in patients with DVT of lower extremities and is beneficial to promoting the life quality of patients.
探讨抗凝(AC)及其联合导管直接溶栓(CDT)治疗下肢深静脉血栓形成的疗效。
选取2011年5月至2013年9月在我院治疗的139例早期下肢深静脉血栓形成患者,随机分为AC组(n = 66)和CDT + AC组(n = 73)。评估溶栓效果、不良反应、血栓形成后综合征(PTS)及生活质量。
两组治疗期间及治疗后均未发生严重不良事件。CDT + AC组观察到2例血肿和3例肉眼血尿。AC组观察到3例牙龈出血或肉眼血尿。与AC组相比,CDT + AC组Ⅰ级溶栓例数显著减少(60.61% 对9.59%)(P < 0.05),Ⅲ级溶栓例数显著增加(7.57% 对49.31%)(P < 0.05)。随访期间,两组PTS发生率均逐年升高,且均无严重PTS患者。CDT + AC组12个月和18个月时PTS发生率低于AC组(17.81% 对33.33%,24.66% 对43.94%)(P < 0.05)。与AC组相比,CDT + AC组6个月、12个月和18个月时生理功能和活力评分更高(P < 0.05)。
导管直接溶栓联合AC治疗可促进下肢深静脉血栓形成患者临床症状的缓解,并有利于提高患者生活质量。